Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses. [electronic resource] by
- Marshall, J L
- Hoyer, R J
- Toomey, M A
- Faraguna, K
- Chang, P
- Richmond, E
- Pedicano, J E
- Gehan, E
- Peck, R A
- Arlen, P
- Tsang, K Y
- Schlom, J
Producer: 20010104
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 18
Availability: No items available.
|